Vaginal progesterone prophylaxis for preterm birth

Affiliations

¹ Department of Obstetrics and Gynaecology, Shrewsbury and Telford Hospitals, NHS Trust, Telford TF1 6TF, UK. Electronic address: dimitrios.papoutsis@nhs.net.
² Department of Midwifery, Midwifery School, Alexander Technological Educational Institute of Thessaloniki, Thessaloniki, Greece.

Comment

Dimitrios Papoutsis et al. Lancet. 2016.

. 2016 Sep 17;388(10050):1159.

doi: 10.1016/S0140-6736(16)31612-9. Epub 2016 Sep 16.

¹ Department of Obstetrics and Gynaecology, Shrewsbury and Telford Hospitals, NHS Trust, Telford TF1 6TF, UK. Electronic address: dimitrios.papoutsis@nhs.net.
² Department of Midwifery, Midwifery School, Alexander Technological Educational Institute of Thessaloniki, Thessaloniki, Greece.

No abstract available

Comment on

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J; OPPTIMUM study group. Norman JE, et al. Lancet. 2016 May 21;387(10033):2106-2116. doi: 10.1016/S0140-6736(16)00350-0. Epub 2016 Feb 24. Lancet. 2016. PMID: 26921136 Free PMC article. Clinical Trial.